Azenta, Inc. (AZTA) Stock
NASDAQ · AZTA
33.24
Fundamentals
Market cap
$1.46B
Price / Earnings ratio
-12.0x
Price / Sales ratio
2.4x
Price / Book ratio
1.0x
Return on assets
-0.1%
Ex-Dividend date
2 Dec 2021
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Azenta, Inc.
No description available.
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees2,900
CEODr. Martin D. Madaus D.V.M., Ph.D.
IPO DateFeb 2, 1995
HeadquartersBurlington, MA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Martin D. Madaus D.V.M., Ph.D. | Interim President, CEO & Director | 1960 |
| Mr. Lawrence Y. Lin | Executive VP & CFO | 1977 |
| Mr. Ephraim Starr | Senior VP, General Counsel & Corporate Secretary | 1972 |
| Ms. Olga Pirogova | Senior VP & Chief HR Officer | 1974 |
| Dr. Ginger Zhou Ph.D. | Advisor | 1977 |
| Mr. Erik J. Bello | Vice President, Chief Accounting Officer & Principal Accounting Officer | — |
| Mr. Michael Paulo | VP, Chief Information & Digital Officer | — |
| Ms. Yvonne Perron | Vice President of Financial Planning & Analysis and Investor Relations | — |
| Mr. William E. Martin III | Senior Vice President & President of Multiomics | 1975 |
| Dr. Andrea O'Hara Ph.D. | Strategic Technical Specialist of Azenta Life Sciences | — |
Fundamentals
Valuation
Market cap$1.46B
Price-to-sales ratio2.40
Price-to-book value0.98
Price-earnings ratio-12.00
Return on Equity-10.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratio0.53
Earnings Per Share
Earnings Per Share$-2.67
Income Statement
Average volume825,189
EBITDA$-156.74M
1 year high (52w)$41.73
1 year low (52w)$15.93
Dividend
Ex dividend date2 Dec 2021
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



